The five-year survival rate for Stage I or Stage II lung cancer is now more than 65%, compared to just 8% for later-Stages III and IV of the disease, according to the American Lung Association. The news was welcomed by Montefiore Einstein Comprehensive Cancer Center (MECCC) officials who said their clinicians are now finding cancers when they are most treatable and curable thanks to enhanced screening, novel care, access to clinical trials, and community education.

MECCC officials said that for several decades, The Bronx has experienced higher-than-average lung cancer mortality rates compared with other New York City boroughs, primarily due to Bronxites being diagnosed at later stages of the disease. They said today’s lifesaving “stage shift,” driven by what they described as “MECCC’s

See Full Page